These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33065955)

  • 1. Safety of IncobotulinumtoxinA in the Treatment of Facial Lines: Results From a Pooled Analysis of Randomized, Prospective, Controlled Clinical Studies.
    Coleman WP; Sattler G; Weissenberger P; Hast MA; Hanschmann A
    Dermatol Surg; 2017 Dec; 43 Suppl 3():S293-S303. PubMed ID: 33065955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
    Kerscher M; Rzany B; Prager W; Turnbull C; Trevidic P; Inglefield C
    Dermatol Surg; 2015 Oct; 41(10):1149-57. PubMed ID: 26359996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study.
    Trevidic P; Connolly SA; Biwer B; Ellers-Lenz B; Harrington LS; Kestemont P; Noah EM; Sattler G; Weissenberger P; Kerscher M
    Dermatol Surg; 2017 Dec; 43 Suppl 3():S285-S292. PubMed ID: 33065954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study.
    Fischer T; Sattler G; Prager W; Rzany B; Pavicic T; Gauglitz G; Weissenberger P; Riaz S
    J Drugs Dermatol; 2020 May; 19(5):461-469. PubMed ID: 32484631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study.
    Pavicic T; Prager W; Klöppel M; Ravichandran S; Galatoire O
    Clin Cosmet Investig Dermatol; 2015; 8():135-42. PubMed ID: 25834463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines.
    Kane MA; Gold MH; Coleman WP; Jones DH; Tanghetti EA; Alster TS; Rohrer TE; Burgess CM; Shamban AT; Finn E
    Dermatol Surg; 2015 Nov; 41(11):1310-9. PubMed ID: 26509943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results for incobotulinumtoxinA in the treatment of glabellar frown lines.
    Rzany B; Flynn TC; Schlöbe A; Heinz M; Harrington L
    Dermatol Surg; 2013 Jan; 39(1 Pt 1):95-103. PubMed ID: 23190342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
    Carruthers A; Carruthers J; Coleman WP; Donofrio L; Flynn T; Gold M; Heinz M; Harrington L; Jones D; McDaniel D; Rohrer T; Schlöbe A; Solish N; Weiss RA
    Dermatol Surg; 2013 Apr; 39(4):551-8. PubMed ID: 23379292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.
    Hanke CW; Narins RS; Brandt F; Cohen JL; Donofrio LM; Downie J; Heinz M; Harrington L; McDaniel DH; Nestor M; Schlessinger J; Schlöbe A; Taub A; Weiss RA
    Dermatol Surg; 2013 Jun; 39(6):891-9. PubMed ID: 23506308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
    Muti GF; Basso M
    J Clin Aesthet Dermatol; 2017 Sep; 10(9):27-29. PubMed ID: 29344324
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and Tolerability of IncobotulinumtoxinA for Treating Glabellar Frown Lines in Korean Adults: A Postmarketing Observational Study.
    Park JY; Sung NK; Pitt JM
    Dermatol Surg; 2017 Dec; 43 Suppl 3():S304-S311. PubMed ID: 28961638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines: A Prospective, Multicenter, Single-arm Study in Taiwan.
    Chao YY; Tseng FW; Yang YL; Chen YH; Hsu NJ; Chang LY
    J Clin Aesthet Dermatol; 2019 Dec; 12(12):E53-E57. PubMed ID: 32038766
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective rater- and subject-blinded study comparing the efficacy of incobotulinumtoxinA and onabotulinumtoxinA to treat crow's feet: a clinical crossover evaluation.
    Muti G; Harrington L
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S39-46. PubMed ID: 25548844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of incobotulinumtoxinA for treatment of glabellar frown lines: a post hoc pooled analysis of 2 randomized, placebo-controlled, phase 3 trials.
    Jones D; Carruthers J; Narins RS; Coleman WP; Harrington L; Brandt FS; Cohen JL
    Dermatol Surg; 2014 Jul; 40(7):776-85. PubMed ID: 25111351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines in Male Subjects: Post-Hoc Analyses From Randomized, Double-Blind Pivotal Studies.
    Jones DH; Kerscher M; Geister T; Hast MA; Weissenberger P
    Dermatol Surg; 2017 Nov; 43 Suppl 2():S235-S241. PubMed ID: 29064991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults.
    Jost WH; Kaňovský P; Hast MA; Hanschmann A; Althaus M; Patel AT
    Toxins (Basel); 2023 May; 15(6):. PubMed ID: 37368654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IncobotulinumtoxinA for Glabellar Frown Lines in Chinese Subjects: A Randomized, Double-blind, Active-Controlled Phase-3 Study.
    Wu Y; Roll S; Klein G; Geister TL; Makara MA; Li B
    Plast Reconstr Surg Glob Open; 2023 May; 11(5):e4956. PubMed ID: 37250827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines.
    Kerscher M; Fabi S; Fischer T; Gold M; Joseph J; Prager W; Rzany B; Yoelin S; Roll S; Klein G; Maas C
    J Drugs Dermatol; 2021 Oct; 20(10):1052-1060. PubMed ID: 34636520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet.
    Saybel A; Artemenko A; Nikitin S; Kurenkov A
    J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.